GLUE Cost of Revenue

Monte Rosa Therapeutics Inc · Cost of Revenue

GLUE logo

GLUE Cost of Revenue

Latest reported$2.03M
GLUE Cost of Revenue ($72.00K → $2.03M)
High-resolution chart · PNG

GLUE cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
8,356,000
8,121,000
6,222,000
0
0
537,000
72,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.